Results · Apr-Jun 2026
TTK Healthcare Q1 FY27 results
StrongStrong: sales up 10% or more & profit up 20% or more on the same quarter last year, with a wider operating margin.
Sales grew 14% to ₹258 crore from ₹226 crore in Apr-Jun 2025.
Operating profit grew 451% to ₹14.7 crore, an operating margin of 5.7% (up 4.5 points from a year ago).
Net profit grew 64% to ₹21.3 crore from ₹13 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +18%, net profit −2%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 257.6 | 226.4 | +14% |
| Operating profit (EBITDA) | 14.7 | 2.7 | +451% |
| Operating margin | 5.7% | 1.2% | +4.5 pts |
| Net profit | 21.3 | 13.0 | +64% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.